Dr Sarah Heynemann is a Melbourne-based early-career medical oncologist, and a PhD candidate with Sydney Health Ethics, The University of Sydney. For her PhD research she is exploring issues at the interface of oncology, novel clinical trials methodology and bioethics, and her work is supported by the NHMRC scholarship scheme. She is actively involved medical education, as a tutor for the University of Melbourne’s Master of Cancer Sciences, as well as within the Monash University medical degree. Until recently she has been an early-career representative on the TOGA scientific committee and has a long-standing research interest in the notion of cancer ‘survivorship’ especially as it conceptualised with respect to the metastatic disease setting.